Synthesis of an Antimicrobial Thioanthraquinone Compound to Produce Biodegradable Electrospun Mats for Tissue Engineering Purposes

Abstract

In the present study for the first time in the literature, novel S-substituted bioactive anthraquinone compound were synthesized with a new, easy and less energetic reaction method (Patent Number: TR2016/19610) from 1-chloro-9,10-dihydrodiagnosisxy-anthraquinone and butyl-3-mercaptopropionate. The resultant structure present remarkable biological properties It was purified by column chromatography. All obtained structures were characterized with spectroscopic methods (NMR, MS, FT-IR, UV etc). Antimicrobial properties of bioactive compound were determined as well. The resultant thioanthraquinone compound has been synthesized for the first time in the literature and its applications as a biomaterial were discussed in the present study.

Subsequently, biodegradable electrospun mats were produced via electrospinning method for their usage in treatment as a biomaterial. Structural (FTIR), morphological (FEG-SEM) biological (antimicrobial and in-vitro tests) and mechanical (tensile testing) characterizations were conducted for these nanobiomaterials. Presenting an advantage of the novel antimicrobial compound, the produced electrospun nanobiocomposites exhibited remarkable biological, mechanical properties. With a purposeful compound synthesis and a subsequent nanobiocomposite production, the obtained electrospun mats are good canditates for biomaterials for tissue engineering purposes and wound healing materials. 

Keywords

• Anthraquinone,synthesis,electrospun mat,biomaterial,biodegradable material,biomaterial

References

1. 1. Ozkok F, Sahin Y M. Biyoaktif Antrakinon Analogları Ve Bunların Sentezine Yönelik Metot. TR. Patent No TR2016/19610.
2. 2. Rath G Ndonzao M, Hostettmann K. Antifungal anthraquinones from Morinda lucida. International journal of pharmacognosy. 1995; 33(2): 107-114.
3. 3. Cowan M M. Plant products as antimicrobial agents. Clinical microbiology reviews. 1999; 12(4): 564-582.
4. 4. Nomura T, Fukai T. Phenolic constituents of licorice (Glycyrrhiza species). In: Fortschritte der Chemie organischer Naturstoffe/Progress in the Chemistry of Organic Natural Products. Springer Vienna, 1998; p 1-140.
5. 5. Ali A M, Ismail N H, Mackeen M M, Yazan L S, Mohamed S M, Ho A S H, Lajis N H. Antiviral, cyototoxic and antimicrobial activities of anthraquinones isolated from the roots of Morinda elliptica. Pharmaceutical Biology. 2000; 38(4): 298-301.
6. 6. Agarwal S K, Singh S S, Verma S, Kumar S. Antifungal activity of anthraquinone derivatives from Rheum emodi. Journal of ethnopharmacology. 2000; 72(1-2): 43-46.
7. 7. Kupchan S M, Karim A. Tumor inhibitors. 114. Aloe emodin: antileukemic principle isolated from Rhamnus frangula L. Lloydia. 1976; 39(4): 223-224.
8. 8. Velasquez W S, Lew D, Grogan TM, Spiridonidis C H, Balcerzak S P, Dakhil S R, Fisher R I. Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501. Journal of clinical oncology. 2003; 21(10): 1996-2003.

9. 9. Thomas X, Archimbaud E. Mitoxantrone in the treatment of acute myelogenous leukemia: a review. Hematology and cell therapy. 1997; 39(4): 163-174.
10. 10. Shenkenberg T D, Von Hoff D D. Mitoxantrone: a new anticancer drug with significant clinical activity. Annals of internal medicine. 1986; 105(1): 67-81.
11. 11. Neuhaus O, Kieseier B C, Hartung H P. Therapeutic role of mitoxantrone in multiple sclerosis. Pharmacology & therapeutics. 2006; 109(1-2): 198-209.
12. 12. Berger T. Current therapeutic recommendations in multiple sclerosis. Journal of the neurological sciences. 2009; 287: S37-S45.
13. 13. Li N, Ma Y, Yang C, Guo L, Yang X. Interaction of anticancer drug mitoxantrone with DNA analyzed by electrochemical and spectroscopic methods. Biophysical chemistry. 2005; 116 (3): 199-205.
14. 14. Lown J W, Morgan A R, Yen S F, Wang Y H, Wilson W D. Characteristics of the binding of the anticancer agents mitoxantrone and ametantrone and related structures to deoxyribonucleic acids. Biochemistry. 1985; 24(15): 4028-4035.
15. 15. Agarwal S, Jangir D P, Mehrotra R. Spectroscopic studies of the effects of anticancer drug mitoxantrone interaction with calf-thymus DNA. Journal of Photochemistry and Photobiology B: Biology. 2013; 120: 177-182.
16. 16. Pommier Y, Leo E, Zhang H, Marchand C. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chemistry & biology. 2010; 17(5): 421-433.
17. 17. Hande K R. Topoisomerase II inhibitors. Update on Cancer Therapeutics. 2008; 3(1): 13-26.
18. 18. Montoya, S. N., Comini, L. R., & Cabrera, J. L. (2011). Antimicrobial activity of natural photosensitizing anthraquinones.
19. 19. Ali, A. M., Ismail, N. H., Mackeen, M. M., Yazan, L. S., Mohamed, S. M., Ho, A. S. H., & Lajis, N. H. (2000). Antiviral, cyototoxic and antimicrobial activities of anthraquinones isolated from the roots of Morinda elliptica. Pharmaceutical Biology, 38(4), 298-301
20. 20. Gouda, M. A., Berghot, M. A., Shoeib, A. I., & Khalil, A. M. (2010). Synthesis and antimicrobial of new anthraquinone derivatives incorporating pyrazole moiety. European journal of medicinal chemistry, 45(5), 1843-1848.
21. 21. Nor, S. M. M., Sukari, M. A. H. M., Azziz, S. S. S. A., Fah, W. C., Alimon, H., & Juhan, S. F. (2013). Synthesis of new cytotoxic aminoanthraquinone derivatives via nucleophilic substitution reactions. Molecules, 18(7), 8046-8062.
22. 22. Routier, S., Cotelle, N., Catteau, J. P., Bernier, J. L., Waring, M. J., Riou, J. F., & Bailly, C. (1996). Salen-anthraquinone conjugates. Synthesis, DNA-binding and cleaving properties, effects on topoisomerases and cytotoxicity. Bioorganic & medicinal chemistry, 4(8), 1185-1196:
23. 23. Ishmael, D. R., & Adelsteinsson, O. (2014). 1, 4, 5, 8-Tetrakis-[(2-N, N-dimethylaminoethyl) amino] anthraquinone as a potential anticancer agent: its synthesis, characterization and anticancer properties.
24. 24. Teng, C. H., Won, S. J., & Lin, C. N. (2005). Design, synthesis and cytotoxic effect of hydroxy-and 3-alkylaminopropoxy-9, 10-anthraquinone derivatives. Bioorganic & medicinal chemistry, 13(10), 3439-3445.
25. 25. Gouda, M. A., Berghot, M. A., Shoeib, A. I., & Khalil, A. M. (2010). Synthesis and antimicrobial of certain new thiazolidinone, thiazoline, and thiophene derivatives. Phosphorus, Sulfur, and Silicon and the Related Elements, 185(7), 1455-1462.
26. 26. Ibis, C., Tuyun, A. F., Bahar, H., Ayla, S. S., Stasevych, M. V., Musyanovych, R. Y., ... & Novikov, V. (2013). Synthesis of novel 1, 4-naphthoquinone derivatives: antibacterial and antifungal agents. Medicinal Chemistry Research, 22(6), 2879-2888.
27. 27. Huang, H. S. (2005). U.S. Patent Application No. 10/615,695.
28. 28. Huang, H. S., Chiou, J. F., Chiu, H. F., Hwang, J. M., Lin, P. Y., Tao, C. W., ... & Jeng, W. R. (2002). Synthesis of symmetrical 1, 5-bis-thio-substituted anthraquinones for cytotoxicity in cultured tumor cells and lipid peroxidation. Chemical and pharmaceutical bulletin, 50(11), 1491-1494.
29. 29. Lord W M, Peters A T. Reactions in NN-dimethylformamide. Part II. Halogen replacement in the anthraquinone series. Journal of the Chemical Society C: Organic. 1968; 783-785.
30. 30. Ruediger E H, Kaldas M L, Gandhi S S, Fedryna C, Gibson M S. Reactions of 1, 5- dichloroanthraquinone with nucleophiles. The Journal of Organic Chemistry. 1980; 45(10): 1974- 1978.
31. 31. Zhang Y, Ouyang H, Lim C T, Ramakrishna S, Huang Z M. Electrospinning of gelatin fibers and gelatin/PCL composite fibrous scaffolds. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2005; 72(1): 156-165.
32. 32. Kehoe S, Zhang, X F, Boyd D. FDA approved guidance conduits and wraps for peripheral nerve injury: a review of materials and efficacy. Injury. 2012; 43(5): 553-572.
33. 33. Polat E. Polikaprolaktonun Elektrostatik Eğirmesi ve Rgd Yüzey Modifikasyonu ile Periferik Sinir İyileşme Kanalları Üretim ve Karakterizasyonu. Fen Bilimleri Enstitüsü, Yüksek Lisans Tezi, 2013 Ankara.
34. 34. Sahin Y M, Su S, Ozbek B, Yucel S, Pinar O, Kazan D, Gunduz O. Production and characterization of electrospun fish sarcoplasmic protein based nanofibers. Journal of Food Engineering. 2018; 222: 54-62.
35. 35. Aliakbarshirazi S, Talebian A. Electrospun gelatin nanofibrous scaffolds for cartilage tissue engineering. Materials Today: Proceedings. 2017; 4(7): 7059-7064.
36. 36. Erdem R, Sancak E. Elektroçekim yöntemiyle elde edilen poliamid 6/kitosan bazlı nanoliflerin morfolojik özelliklerinin incelenmesi. İstanbul Ticaret Üniversitesi Fen Bilimleri Dergisi. 2013; 12.24: 53.
37. 37. Burger C, Hsiao B S, Chu B. Nanofibrous materials and their applications. Annual Review of Materials Research. 2006; 36: 333-368.
38. 38. Buluş E. Doğal izole edilmiş biyoseramiklerden elektrospinning yöntemi ile polimerik biyokompozit malzeme eldesi, Fırat Üniversitesi, Fen Bilimleri Enstitüsü, Yüksek lisans tezi, 2017 Elazığ.
39. 39. Sill T J, Von Recum H A. Electrospinning: applications in drug delivery and tissue engineering. Biomaterials. 2008; 29(13): 1989-2006.
40. 40. Jones R N, Sader H S, Mendes R E, Flamm R K. Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998–2011). Diagnostic microbiology and infectious disease. 2013; 75(1): 107-109.
41. 41. Cuenca-Estrella M, Gomez-Lopez A, Alastruey-Izquierdo A, Bernal-Martinez L, Cuesta I, Buitrago M J, Rodriguez-Tudela J L. Comparison of the Vitek 2 antifungal susceptibility system with the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution reference methods and with the Sensititre YeastOne and Etest techniques for in vitro detection of antifungal resistance in yeast isolates. Journal of clinical microbiology. 2010; 48(5): 1782-1786.
42. 42. Zhu G, Li T. Properties of polyurethane–polystyrene graft copolymer membranes used for separating water–ethanol mixtures. European polymer journal. 2005; 41(5): 1090-1096.
43. 43. Jeevitha D, Amarnath K. Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: Synthesis, characterization and in vitro cytotoxicity evaluation. Colloids and Surfaces B: Biointerfaces. 2013; 101: 126-134.
44. 44. Meng J G, Feng X T, Bai J. Aloe Fiber and Pure Yarn Research on Performance. In: Advanced Materials Research. Trans Tech Publications. 2012; p. 284-288.
45. 45. Oflaz K. Manyetik nanofiber membranlar, Selçuk Üniversitesi, Fen Bilimleri Enstitüsü, Doktora Tezi, 2016 Konya.
46. 46. Liu X, Shao W, Luo M, Bian J, Yu D G. Electrospun Blank Nanocoating for Improved Sustained Release Profiles from Medicated Gliadin Nanofibers. Nanomaterials. 2018; 8(4): 184.
47. 47. Pfaller M A, Farrell D J, Sader H S, Jones R N. AWARE Ceftaroline Surveillance Program (2008– 2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States. Clinical infectious diseases. 2012; 55.suppl_3: S187-S193.
48. 48. Imam S H, Cinelli P, Gordon S H, Chiellini E. Characterization of biodegradable composite films prepared from blends of poly (vinyl alcohol), cornstarch, and lignocellulosic fiber. Journal of Polymers and the Environment. 2005; 13(1): 47-55.
49. 49. Pan H, Fan D, Cao W, Zhu C, Duan Z, Fu R, Ma X. Preparation and Characterization of Breathable Hemostatic Hydrogel Dressings and Determination of Their Effects on Full-Thickness Defects. Polymers. 2017; 9(12): 727.
50. 50. Karp J M, Shoichet M S, Davies J E. Bone formation on two‐dimensional poly (DL‐lactide‐co‐ glycolide)(PLGA) films and three‐dimensional PLGA tissue engineering scaffolds in vitro. Journal of biomedical materials research. Part A 2003; 64(2): 388-396.
51. 51. Çaydamlı Y. Elektrospinning yöntemi ile biyopolimer esaslı nanoyapıların hazırlanması ve karakterizasyonu, Dokuz Eylül Üniversitesi, Fen Bilimleri Enstitüsü, Doktora Tezi, 2012 İzmir.
52. 52. Davila J L, Freitas M S, Inforçatti N P, Silveira Z C, Silva J V L, d’Ávila M A. Fabrication of PCL/β‐ TCP scaffolds by 3D mini‐screw extrusion printing. Journal of Applied Polymer Science. 2016; 133(15).
53. 53. Shakhes J, Zeinaly F, Marandi M A, Saghafi T. The effects of processing variables on the soda and soda-aq pulping of kenaf bast fiber. BioResources. 2011; 6(4): 4626-4639.
54. 54. Kuhn H H. Anthraquinone-2-sulfonic acid doped conductive textiles. U.S. Patent No 5,108,829, 1992.
55. 55. Üstündağ G C. Electrospinning Yöntemi ile Biyomedikal Kullanıma Yönelik Nanolif Yüzey Üretimi ve Uygulaması. Fen Bilimleri Enstitüsü, Yüksek Lisans Tezi, 2009 Bursa.
56. 56. Zeytuncu B. Elektrospinning Tekniği Ve Uv Işımasının Eşzamanlı olarak Uygulanması İle nanofiber Membranların Hazırlanması Ve Kıymetli Metallerin Adsorpsiyonunda Uygulanması, İstanbul Teknik Üniversitesi, Fen Bilimleri Enstitüsü, Doktora Tezi, 2014 İstanbul.
57. 57. Suzuki M. Antibacterial composite non-woven fabric. U.S. Patent No 5,652,049, 1997.
58. 58. Anitha S, Brabu B, Thiruvadigal D J, Gopalakrishnan C, Natarajan T S. Optical, bactericidal and water repellent properties of electrospun nano-composite membranes of cellulose acetate and ZnO. Carbohydrate Polymers. 2012; 87(2): 1065-1072.
59. 59. An Y H, Friedman R J. Concise review of mechanisms of bacterial adhesion to biomaterial surfaces. Journal of Biomedical Materials Research Part A. 1998; 43(3): 338-348.
60. 60. Nilay C A N, Ersoy M S. Nanofiber Structured Polymeric Tissue Scaffolds. 2014; (Volume: 21), 2014, 95.
61. 61. Erem A D. Nanokompozit Yapılı Tekstillerin Geliştirilmesi Ve Antimikrobiyal Özellik Kazandırılması, İstanbul Teknik Üniversitesi, Fen Bilimleri Enstitüsü, Doktora Tezi, 2012 İstanbul.
62. 62. Schiffman J D, Schauer C L. Cross-linking chitosan nanofibers. Biomacromolecules. 2007; 8(2): 594-601.
63. 63. Kayaci F, Um O. C, Tekinay T, Uyar T. Antibacterial electrospun poly (lactic acid)(PLA) nanofibrous webs incorporating triclosan/cyclodextrin inclusion complexes. Journal of agricultural and food chemistry. 2013; 61(16): 3901-3908.
64. 64. Augustine R, Malik H N, Singhal D K, Mukherjee A, Malakar D, Kalarikkal N, Thomas S. Electrospun polycaprolactone/ZnO nanocomposite membranes as biomaterials with antibacterial and cell adhesion properties. Journal of Polymer Research. 2014; 21(3): 347.
65. 65. Lowery J L, Datta N, Rutledge G C. Effect of fiber diameter, pore size and seeding method on growth of human dermal fibroblasts in electrospun poly (ɛ-caprolactone) fibrous mats. Biomaterials. 2010; 31(3): 491-504.
66. 66. Cengiz Çallıoğlu F. The Effect of Glyoxal Cross-Linker and Nacl Salt Addition on The Roller Electrospinning of Poly (Vinyl Alcohol) Nanofibers. Journal of Textile & Apparel/Tekstil ve Konfeksiyon. 2014; 24(1).
67. 67. Kumru A. Elektroüretimle Nanolif Eldesine Etki Eden Faktörlerin Ve Jelatin-pektin İçeren Nanoliflerin Model Gıdaların Reolojik Özelliklerine Etkilerinin İncelenmesi, İstanbul Teknik Üniversitesi, Fen Bilimleri Enstitüsü, Doktora Tezi, 2014 İstanbul.
68. 68. Erdem R, Sancak E. İkili Besleme Ünitesi Sistemi ile Elektroçekimi Gerçekleştirilen PVA/Aloe barbadensis ve PEO/Kitosan Bazlı Nanolifli Yapıların Morfolojik ve Mekanik Özelliklerinin İncelenmesi. Afyon Kocatepe Üniversitesi Fen Ve Mühendislik Bilimleri Dergisi. 2015; 14(1): 1-6.
69. 69. Gaumer J, Prasad A, Lee D, Lannutti J. Structure–function relationships and source-to-ground distance in electrospun polycaprolactone. Acta Biomaterialia. 2009; 5(5): 1552-1561.
70. 70. McClure M J, Sell S A, Simpson D G, Walpoth B H, Bowlin G L. A three-layered electrospun matrix to mimic native arterial architecture using polycaprolactone, elastin, and collagen: a preliminary study. Acta biomaterialia. 2010; 6(7): 2422-2433.
71. 71. Ebersole G C, Buettmann E G, MacEwan M R, Tang M E, Frisella M M, Matthews B D, Deeken C R. Development of novel electrospun absorbable polycaprolactone (PCL) scaffolds for hernia repair applications. Surgical endoscopy. 2012; 26(10): 2717-2728.
72. 72. Lee S J, Oh S H, Liu J, Soker S, Atala A, Yoo J J. The use of thermal treatments to enhance the mechanical properties of electrospun poly (ɛ-caprolactone) scaffolds. Biomaterials. 2008; 29: 1422-1430.